[Contribution of spectrophotometry of the cerebrospinal fluid in the rational treatment of subarachnoid hemorrhage].
In connection with antifibrinolytic therapy of subarachnoid hemorrhage which reduces, especially at the acute stage, the risk of repeated bleeding, more frequent incidence of other serious complications was observed, i.e. late ischemic neurological deficiency. As this complication is prognostically serious and therapeutical effects are not satisfactory its prevention is necessary, which includes administration of antifibrinolytic drugs for a limited time period. Such period may be determined by means of dynamic study of hemoglobin degradation products in the liquor using liquor spectrophotometry.
Krajícková
D
D
Taláb
R
R
D000328:Adult; D000368:Aged; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001663:Bilirubin / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010108:Oxyhemoglobins / Q000134:cerebrospinal fluid*; D013053:Spectrophotometry; D013345:Subarachnoid Hemorrhage / Q000134:cerebrospinal fluid / Q000188:drug therapy*
D000933:Antifibrinolytic Agents; D010108:Oxyhemoglobins; D001663:Bilirubin
Prínos spektrofotometrie likvoru pro racionální lécbu subarachnoidálního krvácení.